For stud breeders, the trial offers a valuable opportunity to validate breeding objectives and demonstrate the commercial relevance of their genetics under real-world production systems. LOOKING AHEAD With additional assessments still to be completed throughout the 2025–2027 trial, the depth of information available to participants will continue to grow. Future reports will further quantify whole-animal productivity, profitability, wool value and lifetime production efficiency, providing one of the most comprehensive evaluations of Merino genetics ever undertaken in Australia. As the Merino industry continues to pursue greater productivity, profitability and sustainability, the AMPT is helping breeders make more informed decisions and identify the genetics best equipped to meet the demands of the future. “The message emerging from the 2026 results is clear: genetic variation matters, objective benchmarking works and the greatest opportunities for industry advancement lie in understanding and harnessing the true capacity of our sheep,” Craig concluded. Discover more about the two new Australian Merino Production Trials commencing in WA in November 2026 and NSW in April 2027. >> australianmerinoproductiontrial.com NEW TRIALS COMING – 13 – Local, specialist & Direct farm insurance Get a quote | Update YOUR policy | Make a claim | general Enquiries 1800 724 214 achmea.com.au Insurance issued by Achmea Schadeverzekeringen N.V. (Achmea) ABN 86 158 237 702 AFSL 433984. Always read the PDS and TMD available from achmea.com.au/important-documents.
RkJQdWJsaXNoZXIy MTI3ODI1